Literature DB >> 7464042

Scanning electron microscopy of cyclophosphamide-induced hyperplasia of the rat urinary bladder.

S Fukushima, M Arai, S M Cohen, J B Jacobs, G H Friedell.   

Abstract

Urinary bladder damage caused by cyclophosphamide in male F344 rats was studied by light microscopy, scanning electron microscopy, and autoradiography. Cyclophosphamide was injected intraperitoneally at doses of 50, 75, 100, 150, and 200 mg. per kg. of body weight, and rats were killed at several intervals following treatment. Extensive necrosis of the bladder was followed by regenerative hyperplasia of the epithelium. A dose response was evident in the number and size of lesions induced and the time of regeneration and repair. Scanning electron microscopy disclosed pleomorphic microvilli on the luminal surface of cells during the early phases of hyperplasia. The greatest number of cells with pleomorphic microvilli occurred 2, 5 and 7 to 8 days following injection of 75, 100, and 200 mg. per kg. of cyclophosphamide, respectively. The hyperplastic lesions also had cells with short, uniform microvilli and ropy or leafy microridges on their surfaces. Autoradiographs of the urinary bladders showed marked labeling of epithelial cells in the early phase of hyperplasia. Of the few rats surviving beyond 1 year after a single injection, none had bladder lesions at any of the dose levels. The changes in the epithelium observed by scanning electron microscopy following cyclophosphamide injection were compared to those observed during bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7464042

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  16 in total

Review 1.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

Review 2.  Formation and maintenance of blood-urine barrier in urothelium.

Authors:  Mateja Erdani Kreft; Samo Hudoklin; Kristijan Jezernik; Rok Romih
Journal:  Protoplasma       Date:  2010-06-04       Impact factor: 3.356

3.  Hyperplasia as a mechanism for rapid resealing urothelial injuries and maintaining high transepithelial resistance.

Authors:  Tanja Višnjar; Petra Kocbek; Mateja Erdani Kreft
Journal:  Histochem Cell Biol       Date:  2011-11-30       Impact factor: 4.304

4.  Expression and localization of four uroplakins in urothelial preneoplastic lesions.

Authors:  Daša Zupančič; Maja Zakrajšek; Ge Zhou; Rok Romih
Journal:  Histochem Cell Biol       Date:  2011-08-19       Impact factor: 4.304

5.  Intravesical epinephrine preserves uroplakin II expression in urinary bladder from cyclophosphamide-induced rat cystitis.

Authors:  Yoon Soo Kyung; Heeyoon Park; Gilho Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-27       Impact factor: 3.000

6.  Melatonin prevents the development of hyperplastic urothelium induced by repeated doses of cyclophosphamide.

Authors:  Dasa Zupancic; Gaj Vidmar; Kristijan Jezernik
Journal:  Virchows Arch       Date:  2009-04-21       Impact factor: 4.064

7.  Effect of hyperthermic vesical irrigation with bleomycin on the ultrastructure of the well-differentiated tumour and non-tumorous mucosa of the human urinary bladder.

Authors:  N Moriyama; M Yokoyama; Y Komine; T Niijima
Journal:  Urol Res       Date:  1983

8.  Comparative light and scanning electron microscopic observations of nasal cavity carcinogenesis in rats treated with 1,4-dinitrosopiperazine.

Authors:  H Tsuda; T Takano; T Shirai; M Suzuki; S Baba; N Ito
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

9.  Reorganisation of the urothelial luminal plasma membrane in the cyclophosphamide treated rats.

Authors:  R Romih; K Jezernik
Journal:  Pflugers Arch       Date:  1996       Impact factor: 3.657

10.  Expressions of uroplakins in the mouse urinary bladder with cyclophosphamide-induced cystitis.

Authors:  Seong Hoo Choi; Youngmin Byun; Gilho Lee
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.